Comprehensive Market Report: Global Iliac Vein Stent Systems Market
Executive Summary
The global Iliac Vein Stent Systems market is a high-growth, specialized segment within the vascular intervention and venous disease management industry. Iliac vein stenting is a minimally invasive procedure primarily used to treat iliac vein compression (May-Thurner Syndrome) and post-thrombotic syndrome, addressing chronic venous insufficiency and deep vein thrombosis. The market, valued at an estimated USD XX million in 2025, is projected to reach approximately USD YY million by 2036, expanding at a robust Compound Annual Growth Rate (CAGR) of Z% from 2026 to 2036. This growth is driven by significant under-diagnosis and rising awareness of venous outflow obstruction, advancements in stent technology tailored for venous anatomy, and a strong clinical shift towards interventional management over conservative therapy. This report provides a strategic analysis of product innovation, clinical adoption, and competitive dynamics.
1. Segments Analysis
By Product Type & Technology:
-
Dedicated Venous Stents (The Growth Engine): Stents specifically engineered for venous applications, characterized by:
-
High Radial Force & Flexibility: To resist extrinsic compression (e.g., from the artery) while conforming to venous anatomy.
-
*Large Diameters (12mm-20mm+):* Sized appropriately for the iliac veins and inferior vena cava (IVC).
-
Open-Cell vs. Closed-Cell Designs: Balancing flexibility with precise placement and scaffolding.
-
-
Nitinol Self-Expanding Stents: The dominant material platform due to its superelasticity, shape memory, and MRI compatibility. Nearly all modern dedicated venous stents are Nitinol-based.
-
Balloon-Expandable Stents: Used less frequently, primarily for very precise placement at the venous confluence or in cases requiring extremely high radial strength.
-
Stent Delivery Systems: Integrated, low-profile delivery catheters designed for precise deployment in large, tortuous veins.
By Stent Design & Feature:
-
Bare Metal Stents: Standard construction.
-
Stent-Grafts / Covered Stents: Used in specific scenarios, such as treatment of venous aneurysms or to prevent tissue ingrowth in tumor-related obstructions.
-
Confluence Stents / Dedicated IVC-Iliac Systems: Designed to treat disease extending into the IVC-iliac vein confluence, a complex anatomical region.
By Indication:
-
Non-Thrombotic Iliac Vein Lesion (NIVL) / May-Thurner Syndrome: The primary and fastest-growing indication as diagnosis improves.
-
Post-Thrombotic Syndrome (PTS): Treatment of chronic obstructions and scarring following deep vein thrombosis (DVT).
-
Chronic Venous Insufficiency (CVI) with Outflow Obstruction: For patients with advanced symptoms (ulcers, severe swelling) where venous outflow blockage is a contributor.
2. Key Players
The market is contested by global vascular device leaders and specialized venous intervention companies.
Leading Companies:
-
Medtronic plc (Leader with its Venovo™ and Abre™ venous stents)
-
Boston Scientific Corporation (Strong portfolio with the VICI VENOUS STENT® system, acquired from Veniti)
-
Cook Medical LLC (Offers the Zilver® Vena venous stent)
-
Gore Medical (W. L. Gore & Associates) (Markets the VIABAHN® VBX balloon-expandable stent graft, used off-label in veins)
-
Cordis (a Cardinal Health company) (Historical leader, re-entering markets)
-
BD (Becton, Dickinson and Company) (Via its peripheral intervention division)
-
Optimed Medizinische Instrumente GmbH (Specialist in dedicated venous stents, e.g., E-Luminexx and sinus-XL)
-
JOTEC GmbH (a CryoLife company) (Offers the E-volution venous stent system)
-
iVascular (Specialized vascular device company)
-
B. Braun Melsungen AG (Through its vascular division)
3. Regional Analysis
-
North America: The largest and most advanced market, particularly the United States. Driven by high procedural adoption, favorable reimbursement (dedicated CPT codes), extensive physician training, and a high level of disease awareness among vascular specialists. The U.S. FDA's approval of dedicated venous stents has catalyzed the market.
-
Europe: A significant market with growing adoption. Key markets include Germany, the UK, France, and Italy. Adoption is supported by clinical guidelines and a strong interventional radiology and vascular surgery community. CE Mark approvals drive product availability.
-
Asia-Pacific: The fastest-growing regional market. Rising healthcare access, increasing diagnosis of venous disease, growing interventional capabilities, and a large patient pool in Japan, China, Australia, and India drive growth. Local manufacturing is emerging.
-
Latin America, Middle East & Africa: Emerging markets with growth concentrated in major metropolitan hospitals and private healthcare centers in Brazil, Mexico, Saudi Arabia, and South Africa. Adoption is limited by cost and access to specialized training.
4. Porter’s Five Forces Analysis
-
Competitive Rivalry (Moderate to High): Competition is intensifying as major medtech companies (Medtronic, Boston Scientific) invest heavily in this high-growth niche. Competition is based on stent performance data (patency rates), ease of delivery, size matrix, and physician training/support. Specialists like Optimed and JOTEC hold strong positions.
-
Bargaining Power of Suppliers (Low to Moderate): Key input is medical-grade Nitinol, supplied by a few global companies (e.g., Confluent Medical, Fort Wayne Metals). While important, stent manufacturers are significant buyers. For specialized coatings or delivery system components, supplier power is moderate.
-
Bargaining Power of Buyers (High): Buyers are large hospital systems and group purchasing organizations (GPOs). They have significant negotiating power, especially as multiple vendors now offer approved products. Physicians influence choice based on clinical preference, but procurement ultimately negotiates price.
-
Threat of New Entrants (Moderate): Barriers are high due to stringent regulatory requirements (FDA PMA, CE Mark), need for robust clinical trials to demonstrate superiority over existing stents, and established physician relationships. However, the high-growth potential attracts well-funded startups and larger companies from adjacent vascular segments.
-
Threat of Substitutes (Low to Moderate): Includes conservative management (compression therapy, medications) and surgical bypass (venovenous or cross-pubic bypass). However, stenting is far less invasive and increasingly demonstrates superior outcomes for outflow obstruction, making it the preferred intervention. The threat lies in non-adoption due to lack of diagnosis.
5. SWOT Analysis
-
Strengths: Addresses a large, under-diagnosed patient population with a minimally invasive, highly effective solution; strong and growing clinical evidence base; high procedure reimbursement in key markets; significant product differentiation potential through stent design.
-
Weaknesses: Procedure requires specialized interventional skills and imaging (IVUS); long-term durability data (10+ years) for newer dedicated stents is still maturing; risk of in-stent restenosis or thrombosis; cost of dedicated systems can be a barrier.
-
Opportunities: Massive under-diagnosis presents a multi-decade growth runway; expansion into adjacent venous territories (femoral, popliteal); development of drug-eluting venous stents to improve long-term patency; integration with intravascular ultrasound (IVUS) for optimized sizing and placement.
-
Threats: Reimbursement challenges or reductions in certain markets; potential for complications (stent migration, fracture, occlusion); competition from "off-label" use of arterial stents at lower cost; lengthy and expensive clinical trials required for new entrants.
6. Trend Analysis, Drivers & Challenges
Key Trends:
-
Routine Use of Intravascular Ultrasound (IVUS): IVUS is becoming the standard for diagnosis, sizing, and post-deployment assessment, driving better outcomes and reinforcing the procedural ecosystem.
-
Focus on Long-Term Patency & Stent Design Optimization: Next-generation stents are focusing on improved fatigue resistance, conformability, and reduced stent-stent interaction in multi-stent procedures.
-
Expansion of Indications & Patient Selection: Moving beyond severe CVI to earlier intervention in symptomatic patients, and treating more complex post-thrombotic anatomy.
-
Specialized Training & Center of Excellence Programs: Companies are investing heavily in physician education to build procedural volume and ensure optimal technique.
Primary Drivers:
-
Improved Diagnosis & Disease Awareness: Greater recognition of iliac vein compression as a cause of chronic leg symptoms, fueled by education and advanced imaging.
-
Strong Clinical Outcomes Data: Robust published data demonstrating symptom relief, ulcer healing, and quality-of-life improvement, driving guideline recommendations.
-
Aging & Obesity Demographics: Both are key risk factors for venous disease, expanding the eligible patient pool.
-
Patient Demand for Minimally Invasive Solutions: Over surgical options or lifelong conservative therapy.
Critical Challenges:
-
Diagnostic Referral Bottleneck: Many primary care physicians and even some vascular specialists remain unaware, delaying patient referral to interventionalists.
-
Procedure Reimbursement Variability: While generally favorable in the US, reimbursement can be inconsistent or inadequate in other regions, hindering adoption.
-
Technical Procedure Complexity: Requires significant operator skill and high-quality imaging, limiting widespread availability.
-
Long-Term Data & Surveillance: Need for ongoing patient follow-up and management of potential late complications.
7. Value Chain Analysis
-
R&D & Clinical Trials: High investment in biomedical engineering (stent design) and conducting pivotal trials for regulatory approval—the critical value-creating step.
-
Advanced Manufacturing: Precision laser cutting, electropolishing, and heat-setting of Nitinol; assembly of delivery systems in clean-room environments.
-
Regulatory Affairs & Market Approval: Navigating complex regulatory pathways (FDA, EMA, NMPA) to obtain approval for venous-specific indications.
-
Marketing, Sales & Physician Education: Highly technical sales focused on interventional radiologists, vascular surgeons, and interventional cardiologists. Extensive investment in workshops, proctoring, and cadaver labs.
-
Procedure Support & Logistics: Ensuring product availability and expert clinical support for complex cases.
-
Post-Market Surveillance & Clinical Support: Monitoring long-term outcomes, managing complications, and supporting publications to reinforce clinical value.
Maximum value is captured by companies that own proprietary stent design IP and successfully execute large-scale clinical trials that define a new standard of care. The physician training and education component is crucial for creating a loyal user base and driving procedure volume.
8. Quick Recommendations for Stakeholders
-
For Market Leaders (Medtronic, Boston Scientific, Cook): Continue to invest in long-term clinical data generation to solidify the standard of care and expand indications. Develop comprehensive "solution" platforms that integrate stents with compatible IVUS systems and sizing tools. Aggressively educate referring physicians (vascular medicine, primary care) to expand the diagnostic funnel. Explore drug-eluting technology for the venous space to address restenosis.
-
For Specialized & Emerging Players (Optimed, JOTEC): Deepen expertise in complex anatomy (post-thrombotic, IVC confluence) where your stents may have a design advantage. Focus on building strong, direct relationships with high-volume venous centers. Consider partnerships for distribution in regions where you lack a direct sales force. Publish robust real-world evidence from your user base.
-
For Healthcare Providers & Hospitals: Invest in IVUS capability and physician training—it is a force-multiplier for procedural success and appropriate patient selection. Establish a dedicated venous practice to concentrate expertise and improve outcomes. Engage with payers to demonstrate the long-term cost-effectiveness of stenting compared to chronic wound care or repeated hospitalizations for DVT.
-
For Patients & Advocacy Groups: Seek evaluation at a center with dedicated venous expertise if suffering from chronic leg symptoms unresponsive to conservative care. Ask about the use of IVUS for diagnosis and treatment planning.
-
For Investors: Focus on companies with FDA-approved dedicated venous stents and a clear pipeline of next-generation products. The market rewards strong clinical data and effective physician training programs. Companies that are successful in driving diagnostic awareness will capture disproportionate growth. The convergence of stent technology with advanced imaging (IVUS) and digital health for follow-up is a key trend to monitor.
Report Basis: History Years: 2020-2024; Base Year: 2025; Forecast Period: 2026-2036.
Note: All market values (XX, YY) and CAGR (Z%) are illustrative placeholders. This analysis reflects the rapid evolution of a formerly niche vascular segment into a mainstream therapy. Customized data, including procedure volume forecasts, competitive product matrix analysis, and reimbursement scenario modeling, is available per client specifications
Table of Contents
Global Iliac Vein Stent Market Research Report 2018
1 Iliac Vein Stent Market Overview
1.1 Product Overview and Scope of Iliac Vein Stent
1.2 Iliac Vein Stent Segment by Type (Product Category)
1.2.1 Global Iliac Vein Stent Production and CAGR (%) Comparison by Type (Product Category)
1.2.2 Global Iliac Vein Stent Production Market Share by Type (Product Category) in
1.2.3 Diameter 10 mm Stent
1.2.4 Diameter 12 mm Stent
1.2.5 Diameter 14 mm Stent
1.2.6 Diameter 16 mm Stent
1.3 Global Iliac Vein Stent Segment by Application
1.3.1 Iliac Vein Stent Consumption (Sales) Comparison by Application
1.3.2 Leg
1.3.3 Chest
1.3.4 Abdomen
1.3.5 Others
1.4 Global Iliac Vein Stent Market by Region
1.4.1 Global Iliac Vein Stent Market Size (Value) and CAGR (%) Comparison by Region
1.4.2 North America Status and Prospect
1.4.3 Europe Status and Prospect
1.4.4 China Status and Prospect
1.4.5 Japan Status and Prospect
1.4.6 Southeast Asia Status and Prospect
1.4.7 India Status and Prospect
1.5 Global Market Size (Value) of Iliac Vein Stent
1.5.1 Global Iliac Vein Stent Revenue Status and Outlook
1.5.2 Global Iliac Vein Stent Capacity, Production Status and Outlook
2 Global Iliac Vein Stent Market Competition by Manufacturers
2.1 Global Iliac Vein Stent Capacity, Production and Share by Manufacturers ()
2.1.1 Global Iliac Vein Stent Capacity and Share by Manufacturers ()
2.1.2 Global Iliac Vein Stent Production and Share by Manufacturers ()
2.2 Global Iliac Vein Stent Revenue and Share by Manufacturers ()
2.3 Global Iliac Vein Stent Average Price by Manufacturers ()
2.4 Manufacturers Iliac Vein Stent Manufacturing Base Distribution, Sales Area and Product Type
2.5 Iliac Vein Stent Market Competitive Situation and Trends
2.5.1 Iliac Vein Stent Market Concentration Rate
2.5.2 Iliac Vein Stent Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Iliac Vein Stent Capacity, Production, Revenue (Value) by Region ()
3.1 Global Iliac Vein Stent Capacity and Market Share by Region ()
3.2 Global Iliac Vein Stent Production and Market Share by Region ()
3.3 Global Iliac Vein Stent Revenue (Value) and Market Share by Region ()
3.4 Global Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
3.5 North America Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
3.6 Europe Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
3.7 China Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
3.8 Japan Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
3.9 Southeast Asia Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
3.10 India Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
4 Global Iliac Vein Stent Supply (Production), Consumption, Export, Import by Region ()
4.1 Global Iliac Vein Stent Consumption by Region ()
4.2 North America Iliac Vein Stent Production, Consumption, Export, Import ()
4.3 Europe Iliac Vein Stent Production, Consumption, Export, Import ()
4.4 China Iliac Vein Stent Production, Consumption, Export, Import ()
4.5 Japan Iliac Vein Stent Production, Consumption, Export, Import ()
4.6 Southeast Asia Iliac Vein Stent Production, Consumption, Export, Import ()
4.7 India Iliac Vein Stent Production, Consumption, Export, Import ()
5 Global Iliac Vein Stent Production, Revenue (Value), Price Trend by Type
5.1 Global Iliac Vein Stent Production and Market Share by Type ()
5.2 Global Iliac Vein Stent Revenue and Market Share by Type ()
5.3 Global Iliac Vein Stent Price by Type ()
5.4 Global Iliac Vein Stent Production Growth by Type ()
6 Global Iliac Vein Stent Market Analysis by Application
6.1 Global Iliac Vein Stent Consumption and Market Share by Application ()
6.2 Global Iliac Vein Stent Consumption Growth Rate by Application ()
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Iliac Vein Stent Manufacturers Profiles/Analysis
7.1 Boston Scientific
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Iliac Vein Stent Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Boston Scientific Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
7.1.4 Main Business/Business Overview
7.2 Bard
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Iliac Vein Stent Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bard Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
7.2.4 Main Business/Business Overview
7.3 Veniti
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Iliac Vein Stent Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Veniti Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
7.3.4 Main Business/Business Overview
7.4 Cook Medical
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Iliac Vein Stent Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Cook Medical Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
7.4.4 Main Business/Business Overview
7.5 Medtronic
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Iliac Vein Stent Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Medtronic Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Optimed Med
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Iliac Vein Stent Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Optimed Med Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
7.6.4 Main Business/Business Overview
7.7 Jotec
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Iliac Vein Stent Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Jotec Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
7.7.4 Main Business/Business Overview
7.8 Gore Medical
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Iliac Vein Stent Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Gore Medical Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
7.8.4 Main Business/Business Overview
7.9 Abbott
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Iliac Vein Stent Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Abbott Iliac Vein Stent Capacity, Production, Revenue, Price and Gross Margin ()
7.9.4 Main Business/Business Overview
8 Iliac Vein Stent Manufacturing Cost Analysis
8.1 Iliac Vein Stent Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Iliac Vein Stent
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Iliac Vein Stent Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Iliac Vein Stent Major Manufacturers in
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Iliac Vein Stent Market Forecast (2018-2025)
12.1 Global Iliac Vein Stent Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Iliac Vein Stent Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Iliac Vein Stent Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Iliac Vein Stent Price and Trend Forecast (2018-2025)
12.2 Global Iliac Vein Stent Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Iliac Vein Stent Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Iliac Vein Stent Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Iliac Vein Stent Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Iliac Vein Stent Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Iliac Vein Stent Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Iliac Vein Stent Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Iliac Vein Stent Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Iliac Vein Stent Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Iliac Vein Stent
Figure Global Iliac Vein Stent Production () and CAGR (%) Comparison by Types (Product Category)
Figure Global Iliac Vein Stent Production Market Share by Types (Product Category) in
Figure Product Picture of Diameter 10 mm Stent
Table Major Manufacturers of Diameter 10 mm Stent
Figure Product Picture of Diameter 12 mm Stent
Table Major Manufacturers of Diameter 12 mm Stent
Figure Product Picture of Diameter 14 mm Stent
Table Major Manufacturers of Diameter 14 mm Stent
Figure Product Picture of Diameter 16 mm Stent
Table Major Manufacturers of Diameter 16 mm Stent
Figure Global Iliac Vein Stent Consumption (Units) by Applications
Figure Global Iliac Vein Stent Consumption Market Share by Applications in
Figure Leg Examples
Table Key Downstream Customer in Leg
Figure Chest Examples
Table Key Downstream Customer in Chest
Figure Abdomen Examples
Table Key Downstream Customer in Abdomen
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Iliac Vein Stent Market Size (Million USD), Comparison (Units) and CAGR (%) by Regions
Figure North America Iliac Vein Stent Revenue (Million USD) and Growth Rate
Figure Europe Iliac Vein Stent Revenue (Million USD) and Growth Rate
Figure China Iliac Vein Stent Revenue (Million USD) and Growth Rate
Figure Japan Iliac Vein Stent Revenue (Million USD) and Growth Rate
Figure Southeast Asia Iliac Vein Stent Revenue (Million USD) and Growth Rate
Figure India Iliac Vein Stent Revenue (Million USD) and Growth Rate
Figure Global Iliac Vein Stent Revenue (Million USD) Status and Outlook
Figure Global Iliac Vein Stent Capacity, Production (Units) Status and Outlook
Figure Global Iliac Vein Stent Major Players Product Capacity (Units) ()
Table Global Iliac Vein Stent Capacity (Units) of Key Manufacturers ()
Table Global Iliac Vein Stent Capacity Market Share of Key Manufacturers ()
Figure Global Iliac Vein Stent Capacity (Units) of Key Manufacturers in
Figure Global Iliac Vein Stent Capacity (Units) of Key Manufacturers in 2018
Figure Global Iliac Vein Stent Major Players Product Production (Units) ()
Table Global Iliac Vein Stent Production (Units) of Key Manufacturers ()
Table Global Iliac Vein Stent Production Share by Manufacturers ()
Figure Iliac Vein Stent Production Share by Manufacturers
Figure Iliac Vein Stent Production Share by Manufacturers
Figure Global Iliac Vein Stent Major Players Product Revenue (Million USD) ()
Table Global Iliac Vein Stent Revenue (Million USD) by Manufacturers ()
Table Global Iliac Vein Stent Revenue Share by Manufacturers ()
Table Global Iliac Vein Stent Revenue Share by Manufacturers
Table 2018 Global Iliac Vein Stent Revenue Share by Manufacturers
Table Global Market Iliac Vein Stent Average Price (K USD/Unit) of Key Manufacturers ()
Figure Global Market Iliac Vein Stent Average Price (K USD/Unit) of Key Manufacturers in
Table Manufacturers Iliac Vein Stent Manufacturing Base Distribution and Sales Area
Table Manufacturers Iliac Vein Stent Product Category
Figure Iliac Vein Stent Market Share of Top 3 Manufacturers
Figure Iliac Vein Stent Market Share of Top 5 Manufacturers
Table Global Iliac Vein Stent Capacity (Units) by Region ()
Figure Global Iliac Vein Stent Capacity Market Share by Region ()
Figure Global Iliac Vein Stent Capacity Market Share by Region ()
Figure Global Iliac Vein Stent Capacity Market Share by Region
Table Global Iliac Vein Stent Production by Region ()
Figure Global Iliac Vein Stent Production (Units) by Region ()
Figure Global Iliac Vein Stent Production Market Share by Region ()
Figure Global Iliac Vein Stent Production Market Share by Region
Table Global Iliac Vein Stent Revenue (Million USD) by Region ()
Table Global Iliac Vein Stent Revenue Market Share by Region ()
Figure Global Iliac Vein Stent Revenue Market Share by Region ()
Table Global Iliac Vein Stent Revenue Market Share by Region
Figure Global Iliac Vein Stent Capacity, Production (Units) and Growth Rate ()
Table Global Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Table North America Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Table Europe Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Table China Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Table Japan Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Table China Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Table Japan Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Table Global Iliac Vein Stent Consumption (Units) Market by Region ()
Table Global Iliac Vein Stent Consumption Market Share by Region ()
Figure Global Iliac Vein Stent Consumption Market Share by Region ()
Figure Global Iliac Vein Stent Consumption (Units) Market Share by Region
Table North America Iliac Vein Stent Production, Consumption, Import & Export (Units) ()
Table Europe Iliac Vein Stent Production, Consumption, Import & Export (Units) ()
Table China Iliac Vein Stent Production, Consumption, Import & Export (Units) ()
Table Japan Iliac Vein Stent Production, Consumption, Import & Export (Units) ()
Table Southeast Asia Iliac Vein Stent Production, Consumption, Import & Export (Units) ()
Table India Iliac Vein Stent Production, Consumption, Import & Export (Units) ()
Table Global Iliac Vein Stent Production (Units) by Type ()
Table Global Iliac Vein Stent Production Share by Type ()
Figure Production Market Share of Iliac Vein Stent by Type ()
Figure Production Market Share of Iliac Vein Stent by Type
Table Global Iliac Vein Stent Revenue (Million USD) by Type ()
Table Global Iliac Vein Stent Revenue Share by Type ()
Figure Production Revenue Share of Iliac Vein Stent by Type ()
Figure Revenue Market Share of Iliac Vein Stent by Type
Table Global Iliac Vein Stent Price (K USD/Unit) by Type ()
Figure Global Iliac Vein Stent Production Growth by Type ()
Table Global Iliac Vein Stent Consumption (Units) by Application ()
Table Global Iliac Vein Stent Consumption Market Share by Application ()
Figure Global Iliac Vein Stent Consumption Market Share by Applications ()
Figure Global Iliac Vein Stent Consumption Market Share by Application in
Table Global Iliac Vein Stent Consumption Growth Rate by Application ()
Figure Global Iliac Vein Stent Consumption Growth Rate by Application ()
Table Boston Scientific Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boston Scientific Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (Boston Scientific) and Gross Margin ()
Figure Boston Scientific Iliac Vein Stent Production Growth Rate ()
Figure Boston Scientific Iliac Vein Stent Production Market Share ()
Figure Boston Scientific Iliac Vein Stent Revenue Market Share ()
Table Bard Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bard Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Figure Bard Iliac Vein Stent Production Growth Rate ()
Figure Bard Iliac Vein Stent Production Market Share ()
Figure Bard Iliac Vein Stent Revenue Market Share ()
Table Veniti Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Veniti Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Figure Veniti Iliac Vein Stent Production Growth Rate ()
Figure Veniti Iliac Vein Stent Production Market Share ()
Figure Veniti Iliac Vein Stent Revenue Market Share ()
Table Cook Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cook Medical Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Figure Cook Medical Iliac Vein Stent Production Growth Rate ()
Figure Cook Medical Iliac Vein Stent Production Market Share ()
Figure Cook Medical Iliac Vein Stent Revenue Market Share ()
Table Medtronic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Medtronic Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Figure Medtronic Iliac Vein Stent Production Growth Rate ()
Figure Medtronic Iliac Vein Stent Production Market Share ()
Figure Medtronic Iliac Vein Stent Revenue Market Share ()
Table Optimed Med Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Optimed Med Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Figure Optimed Med Iliac Vein Stent Production Growth Rate ()
Figure Optimed Med Iliac Vein Stent Production Market Share ()
Figure Optimed Med Iliac Vein Stent Revenue Market Share ()
Table Jotec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jotec Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Figure Jotec Iliac Vein Stent Production Growth Rate ()
Figure Jotec Iliac Vein Stent Production Market Share ()
Figure Jotec Iliac Vein Stent Revenue Market Share ()
Table Gore Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gore Medical Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Figure Gore Medical Iliac Vein Stent Production Growth Rate ()
Figure Gore Medical Iliac Vein Stent Production Market Share ()
Figure Gore Medical Iliac Vein Stent Revenue Market Share ()
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Iliac Vein Stent Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin ()
Figure Abbott Iliac Vein Stent Production Growth Rate ()
Figure Abbott Iliac Vein Stent Production Market Share ()
Figure Abbott Iliac Vein Stent Revenue Market Share ()
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Iliac Vein Stent
Figure Manufacturing Process Analysis of Iliac Vein Stent
Figure Iliac Vein Stent Industrial Chain Analysis
Table Raw Materials Sources of Iliac Vein Stent Major Manufacturers in
Table Major Buyers of Iliac Vein Stent
Table Distributors/Traders List
Figure Global Iliac Vein Stent Capacity, Production (Units) and Growth Rate Forecast (2018-2025)
Figure Global Iliac Vein Stent Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Iliac Vein Stent Price (Million USD) and Trend Forecast (2018-2025)
Table Global Iliac Vein Stent Production (Units) Forecast by Region (2018-2025)
Figure Global Iliac Vein Stent Production Market Share Forecast by Region (2018-2025)
Table Global Iliac Vein Stent Consumption (Units) Forecast by Region (2018-2025)
Figure Global Iliac Vein Stent Consumption Market Share Forecast by Region (2018-2025)
Figure North America Iliac Vein Stent Production (Units) and Growth Rate Forecast (2018-2025)
Figure North America Iliac Vein Stent Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Iliac Vein Stent Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Figure Europe Iliac Vein Stent Production (Units) and Growth Rate Forecast (2018-2025)
Figure Europe Iliac Vein Stent Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Iliac Vein Stent Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Figure China Iliac Vein Stent Production (Units) and Growth Rate Forecast (2018-2025)
Figure China Iliac Vein Stent Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Iliac Vein Stent Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Figure Japan Iliac Vein Stent Production (Units) and Growth Rate Forecast (2018-2025)
Figure Japan Iliac Vein Stent Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Iliac Vein Stent Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Figure Southeast Asia Iliac Vein Stent Production (Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Iliac Vein Stent Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Iliac Vein Stent Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Figure India Iliac Vein Stent Production (Units) and Growth Rate Forecast (2018-2025)
Figure India Iliac Vein Stent Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Iliac Vein Stent Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Table Global Iliac Vein Stent Production (Units) Forecast by Type (2018-2025)
Figure Global Iliac Vein Stent Production (Units) Forecast by Type (2018-2025)
Table Global Iliac Vein Stent Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Iliac Vein Stent Revenue Market Share Forecast by Type (2018-2025)
Table Global Iliac Vein Stent Price Forecast by Type (2018-2025)
Table Global Iliac Vein Stent Consumption (Units) Forecast by Application (2018-2025)
Figure Global Iliac Vein Stent Consumption (Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
1. Segments Analysis
By Product Type & Technology:
-
Dedicated Venous Stents (The Growth Engine): Stents specifically engineered for venous applications, characterized by:
-
High Radial Force & Flexibility: To resist extrinsic compression (e.g., from the artery) while conforming to venous anatomy.
-
*Large Diameters (12mm-20mm+):* Sized appropriately for the iliac veins and inferior vena cava (IVC).
-
Open-Cell vs. Closed-Cell Designs: Balancing flexibility with precise placement and scaffolding.
-
-
Nitinol Self-Expanding Stents: The dominant material platform due to its superelasticity, shape memory, and MRI compatibility. Nearly all modern dedicated venous stents are Nitinol-based.
-
Balloon-Expandable Stents: Used less frequently, primarily for very precise placement at the venous confluence or in cases requiring extremely high radial strength.
-
Stent Delivery Systems: Integrated, low-profile delivery catheters designed for precise deployment in large, tortuous veins.
By Stent Design & Feature:
-
Bare Metal Stents: Standard construction.
-
Stent-Grafts / Covered Stents: Used in specific scenarios, such as treatment of venous aneurysms or to prevent tissue ingrowth in tumor-related obstructions.
-
Confluence Stents / Dedicated IVC-Iliac Systems: Designed to treat disease extending into the IVC-iliac vein confluence, a complex anatomical region.
By Indication:
-
Non-Thrombotic Iliac Vein Lesion (NIVL) / May-Thurner Syndrome: The primary and fastest-growing indication as diagnosis improves.
-
Post-Thrombotic Syndrome (PTS): Treatment of chronic obstructions and scarring following deep vein thrombosis (DVT).
-
Chronic Venous Insufficiency (CVI) with Outflow Obstruction: For patients with advanced symptoms (ulcers, severe swelling) where venous outflow blockage is a contributor.
2. Key Players
The market is contested by global vascular device leaders and specialized venous intervention companies.
Leading Companies:
-
Medtronic plc (Leader with its Venovo™ and Abre™ venous stents)
-
Boston Scientific Corporation (Strong portfolio with the VICI VENOUS STENT® system, acquired from Veniti)
-
Cook Medical LLC (Offers the Zilver® Vena venous stent)
-
Gore Medical (W. L. Gore & Associates) (Markets the VIABAHN® VBX balloon-expandable stent graft, used off-label in veins)
-
Cordis (a Cardinal Health company) (Historical leader, re-entering markets)
-
BD (Becton, Dickinson and Company) (Via its peripheral intervention division)
-
Optimed Medizinische Instrumente GmbH (Specialist in dedicated venous stents, e.g., E-Luminexx and sinus-XL)
-
JOTEC GmbH (a CryoLife company) (Offers the E-volution venous stent system)
-
iVascular (Specialized vascular device company)
-
B. Braun Melsungen AG (Through its vascular division)
